CYNTHIA KAYLOR: Open Payments
NPI 1174573299 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 67 payments from 15 companies in 2025. Trend: 2023 $1,350 · 2024 $1,109 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $417 |
| Amgen Inc. | 19 | $180 |
| Edwards Lifesciences Corporation | 2 | $128 |
| PFIZER INC. | 5 | $122 |
| Merck Sharp & Dohme LLC | 5 | $91 |
| Corcept Therapeutics | 2 | $51 |
| AngioDynamics, Inc. | 2 | $36 |
| BridgeBio Pharma, Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
Products named: LEQVIO, REPATHA, VYNDAQEL, VERQUVO, Korlym, ENTRESTO, ALPHAVAC, CAPVAXIVE.
Industry payments across NY — which companies pay providers there.
